209 related articles for article (PubMed ID: 16081427)
1. Skin biopsy rates and incidence of melanoma: population based ecological study.
Welch HG; Woloshin S; Schwartz LM
BMJ; 2005 Sep; 331(7515):481. PubMed ID: 16081427
[TBL] [Abstract][Full Text] [Related]
2. Skin biopsy utilization and melanoma incidence among Medicare beneficiaries.
Weinstock MA; Lott JP; Wang Q; Titus LJ; Onega T; Nelson HD; Pearson L; Piepkorn M; Barnhill RL; Elmore JG; Tosteson ANA
Br J Dermatol; 2017 Apr; 176(4):949-954. PubMed ID: 27639256
[TBL] [Abstract][Full Text] [Related]
3. Delay of Surgery for Melanoma Among Medicare Beneficiaries.
Lott JP; Narayan D; Soulos PR; Aminawung J; Gross CP
JAMA Dermatol; 2015 Jul; 151(7):731-41. PubMed ID: 25853865
[TBL] [Abstract][Full Text] [Related]
4. Economic burden of melanoma in the elderly population: population-based analysis of the Surveillance, Epidemiology, and End Results (SEER)--Medicare data.
Seidler AM; Pennie ML; Veledar E; Culler SD; Chen SC
Arch Dermatol; 2010 Mar; 146(3):249-56. PubMed ID: 20231494
[TBL] [Abstract][Full Text] [Related]
5. The effect of screening on melanoma incidence and biopsy rates.
Whiteman DC; Olsen CM; MacGregor S; Law MH; Thompson B; Dusingize JC; Green AC; Neale RE; Pandeya N;
Br J Dermatol; 2022 Oct; 187(4):515-522. PubMed ID: 35531668
[TBL] [Abstract][Full Text] [Related]
6. Temporal trends in healthcare utilization following primary melanoma diagnosis among Medicare beneficiaries.
Lott JP; Wang Q; Titus LJ; Onega T; Nelson HD; Weinstock MA; Elmore JG; Tosteson ANA
Br J Dermatol; 2017 Sep; 177(3):845-853. PubMed ID: 28369774
[TBL] [Abstract][Full Text] [Related]
7. Reporting cutaneous melanoma to cancer registries in the United States.
Hall HI; Jamison P; Fulton JP; Clutter G; Roffers S; Parrish P
J Am Acad Dermatol; 2003 Oct; 49(4):624-30. PubMed ID: 14512907
[TBL] [Abstract][Full Text] [Related]
8. Early detection of thick melanomas in the United States: beware of the nodular subtype.
Demierre MF; Chung C; Miller DR; Geller AC
Arch Dermatol; 2005 Jun; 141(6):745-50. PubMed ID: 15967921
[TBL] [Abstract][Full Text] [Related]
9. Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006.
Jemal A; Saraiya M; Patel P; Cherala SS; Barnholtz-Sloan J; Kim J; Wiggins CL; Wingo PA
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S17-25.e1-3. PubMed ID: 22018063
[TBL] [Abstract][Full Text] [Related]
10. Incidence of In Situ and Invasive Melanoma in Denmark From 1985 Through 2012: A National Database Study of 24,059 Melanoma Cases.
Helvind NM; Hölmich LR; Smith S; Glud M; Andersen KK; Dalton SO; Drzewiecki KT
JAMA Dermatol; 2015 Oct; 151(10):1087-95. PubMed ID: 26061591
[TBL] [Abstract][Full Text] [Related]
11. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.
Coory M; Baade P; Aitken J; Smithers M; McLeod GR; Ring I
Cancer Causes Control; 2006 Feb; 17(1):21-7. PubMed ID: 16411049
[TBL] [Abstract][Full Text] [Related]
12. The characterization and potential impact of melanoma cases with unknown thickness in the United States' Surveillance, Epidemiology, and End Results Program, 1989-2008.
Shaikh WR; Weinstock MA; Halpern AC; Oliveria SA; Geller AC; Dusza SW
Cancer Epidemiol; 2013 Feb; 37(1):64-70. PubMed ID: 22995853
[TBL] [Abstract][Full Text] [Related]
13. Incidence of cutaneous malignant melanoma in the Ottawa region: 1996 to 2006.
Nevins T; Su Y; Doucette S; Kanigsberg N
J Cutan Med Surg; 2008; 12(6):276-81. PubMed ID: 19317949
[TBL] [Abstract][Full Text] [Related]
14. Pediatric Melanoma: Geographic Trends in Incidence, Stage, and Mortality in the United States.
Borad A; Deianni E; Peña K; Burjonrappa S
J Surg Res; 2023 Oct; 290():215-220. PubMed ID: 37285703
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry.
Dennis LK
Arch Dermatol; 1999 Mar; 135(3):275-80. PubMed ID: 10086448
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry for Diagnosing Melanoma in Older Adults.
Ojukwu K; Eguchi MM; Adamson AS; Kerr KF; Piepkorn MW; Murdoch S; Barnhill RL; Elder DE; Knezevich SR; Elmore JG
JAMA Dermatol; 2024 Apr; 160(4):434-440. PubMed ID: 38446470
[TBL] [Abstract][Full Text] [Related]
17. Patient presentation, skin biopsy utilization and cutaneous malignant melanoma incidence and mortality in northern Italy: Trends and correlations.
Bucchi L; Mancini S; Zamagni F; Crocetti E; Dal Maso L; Ferretti S; Baldacchini F; Giuliani O; Ravaioli A; Vattiato R; Brustolin A; Candela G; Carone S; Carrozzi G; Cavallo R; Dinaro YM; Ferrante M; Iacovacci S; Mazzoleni G; Musolino A; Rizzello RV; Serraino D; Biggeri A; Stanganelli I; Falcini F;
J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):293-302. PubMed ID: 36181283
[TBL] [Abstract][Full Text] [Related]
18. The melanoma epidemic debate: some evidence for a real phenomenon from Tuscany, Italy.
Chellini E; Crocetti E; Carli P; Martini A; Giovannetti L
Melanoma Res; 2007 Apr; 17(2):129-30. PubMed ID: 17496788
[TBL] [Abstract][Full Text] [Related]
19. Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005.
Pruthi DK; Guilfoyle R; Nugent Z; Wiseman MC; Demers AA
J Am Acad Dermatol; 2009 Jul; 61(1):44-50. PubMed ID: 19395122
[TBL] [Abstract][Full Text] [Related]
20. A population-based study of cutaneous melanoma in Alberta, Canada (1993-2002).
Metelitsa AI; Dover DC; Smylie M; de Gara CJ; Lauzon GJ
J Am Acad Dermatol; 2010 Feb; 62(2):227-32. PubMed ID: 20018405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
